EXTERNAL CONTROL TEMPLATE

This template controls the elements:

TOP: Top Links (Home, Donate, Events, Contact), Social Network Buttons, Tagline, Tagline Image

FOOTER: Footer Links (Privacy Policy, Contact, Donate), Footer Descriptions

* This message is only visible in administrative mode
Stomach Cancer Blog

 

To comment on the blog entries you must be a member
of our site. Please CLICK HERE
to sign in or register.

 

Scroll down to view the different blog entries and topics.  Check this page regularly for new blog topics.  Please email us with your suggestions for new blog topics at Patient.Resource@DebbiesDream.org.

Disclaimer

Debbie's Dream Foundation: Curing Stomach Cancer ("DDF") is not a substitute for medical advice, diagnosis, treatment or other health care services. DDF may provide information to you about physicians, products, services, clinical trials or treatments related to stomach cancer, but DDF does not recommend nor endorse any particular health care resource. In addition, please note that any personal information you provide to DDF's associates during telephone and/or email communications may be stored and used to help DDF achieve its mission of assisting patients with, and finding cures and treatments for, stomach cancer. Stored constituent information may be used to inform DDF programs and activities. Information also may be provided in aggregate or limited formats to third parties to guide future stomach cancer research and treatment efforts. DDF will not provide personal directly identifying information (such as your name or contact information) to such third parties without your prior written consent unless required or permitted by law to do so.

According to MENAFN – Proactive Investors, “Her-Vaxx is a proprietary peptide vaccine or immunotherapy that causes the immune system to generate cancer-fighting antibodies.” Imugene, the
It’s understandable that you may feel a little nervous or anxious the day of your first visit to your oncologist. Here are seven tips for making the most of your first visit and having a
Imugene has raised $3.5 million in capital to help pay for trials of its Her-Vaxx anticancer candidate.  The funds will be used to manufacture the drug and help fund its Phase Ib/II trial for
This spring, studies will be conducted to screen tumors in thousands of patients in order to see which might be attacked by at least a dozen new drugs. These studies will be done by a federally
Merck & Co.’s new drug, Keytruda, is a type of immuno-oncology drug that fights cancer by giving T cells the opportunity to attack hidden cancer cells.  Stomach cancer is one of many
RSS (Opens New Window)
Showing 1 - 5 of 56 results.
of 12